SCHEMBL1841996

SCHEMBL1841996

C=CCCCCCCCC=C(C)C(=O)O

nearest known ligand 0.52

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
MAPT P10636 3/20 0.52
ABCC4 O15439 1/20 0.52
ALDH1A1 P00352 4/20 0.46
LMNA P02545 2/20 0.46
EP300 Q09472 1/20 0.44
TSHR P16473 2/20 0.43
USP2 O75604 2/20 0.40
CYP3A4 P08684 2/20 0.40
SMN1; SMN2 Q16637 2/20 0.40
RECQL P46063 1/20 0.40
TBXAS1 P24557 1/20 0.40
HPGD P15428 1/20 0.39
LPAR2 Q9HBW0 1/20 0.37
LPAR3 Q9UBY5 1/20 0.37
CD81 P60033 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26098086 1.00 MAPT (0.52) MAPTABCC4ALDH1A1LMNAEP300
SCHEMBL26098911 1.00 MAPT (0.52) MAPTABCC4ALDH1A1LMNAEP300
SCHEMBL26098418 1.00 MAPT (0.52) MAPTABCC4ALDH1A1LMNAEP300
SCHEMBL26097100 1.00 MAPT (0.52) MAPTABCC4ALDH1A1LMNAEP300
SCHEMBL9463901 1.00 MAPT (0.52) MAPTABCC4ALDH1A1LMNAEP300
SCHEMBL26097766 1.00 MAPT (0.52) MAPTABCC4ALDH1A1LMNAEP300
SCHEMBL9463894 1.00 MAPT (0.52) MAPTABCC4ALDH1A1LMNAEP300
SCHEMBL26097631 1.00 MAPT (0.52) MAPTABCC4ALDH1A1LMNAEP300
SCHEMBL26097585 1.00 MAPT (0.52) MAPTABCC4ALDH1A1LMNAEP300
SCHEMBL26098646 1.00 MAPT (0.52) MAPTABCC4ALDH1A1LMNAEP300

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230134471-A1 METHOD FOR PRODUCING (METH)ACRYLOXY GROUP-CONTAINING ORGANOSILICON COMPOUNDS SHIN-ETSU CHEMICAL CO., LTD. (JP) 2023-05-04 US disclosed
EP-2321123-B1 METALLIZED PARTICLES FORMED FROM A DISPERSION DOW SILICONES CORP (US) 2018-08-08 EP disclosed
US-8715828-B2 Emulsion of metallized particles comprising a compound having a pendant Si-H group DOW CORNING CORPORATION (US) 2014-05-06 US disclosed
EP-2212457-B1 ARTICLE AND METHOD OF MANUFACTURING SAME DOW CORNING (US) 2013-07-24 EP disclosed
US-20110171471-A1 Metallized Particles Formed From A Dispersion DOW SILICONES CORPORATION 2011-07-14 US disclosed
EP-2321123-A2 METALLIZED PARTICLES FORMED FROM A DISPERSION Dow Corning Corporation (US) 2011-05-18 EP disclosed
US-20100255745-A1 Article And Method Of Manufacturing Same DOW CORNING CORPORATION 2010-10-07 US disclosed
EP-2212457-A1 ARTICLE AND METHOD OF MANUFACTURING SAME Dow Corning Corporation (US) 2010-08-04 EP disclosed
WO-2010025140-A2 METALLIZED PARTICLES FORMED FROM A DISPERSION DOW CORNING CORPORATION (US) 2010-03-04 WO disclosed
WO-2009067230-A1 ARTICLE AND METHOD OF MANUFACTURING SAME DOW CORNING CORPORATION (US) 2009-05-28 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230134471-A1 METHOD FOR PRODUCING (METH)ACRYLOXY GROUP-CONTAINING ORGANOSILICON COMPOUNDS HM13, RPS13, GRHPR MAPT 4369/4885ABCC4 4165/4885ALDH1A1 1759/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.